JBS (JBS) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
11 Aug, 2026Executive summary
Net sales reached a record $23.9 billion in 2Q26, a 14% year-over-year increase, but profitability declined with a net loss of $102 million and adjusted net income of $218 million, mainly due to non-recurring items and high cattle prices.
Adjusted EBITDA (IFRS) was $1.43 billion (6.0% margin), down 18% year-over-year, and adjusted operating income was $790 million (3.3% margin).
Adjusted EPS was $0.20, compared to $0.52 in 2Q25; reported EPS was -$0.10.
Significant non-recurring items included $172 million in bond/CRA costs, $133 million in antitrust settlements, and an $81 million gain from an acquisition.
$1 billion was returned to shareholders via dividends, and the company joined the Russell 1000 and 3000 indices, enhancing global visibility.
Financial highlights
Gross profit for 2Q26 was $2.59 billion, down from $2.83 billion in 2Q25.
Free cash flow improved to $130 million from a negative $55 million in 2Q25, driven by working capital improvements.
Net leverage ended at 3.1x, above the long-term target; interest coverage was 5.0x.
ROE LTM was 13.4%, down from 25.7% a year earlier; ROIC LTM was 13.4%.
Average debt term extended to 15.3 years at a 5.7% average cost; total liquidity at $7.7 billion.
Outlook and guidance
Profitability is expected to improve sequentially, supported by operational efficiency, investments in branded and value-added products, and resumption of live cattle imports from Mexico.
Ongoing investments in geographic diversification and prepared foods are expected to support future margins.
Management expects continued volatility in commodity and energy markets due to geopolitical tensions and inflationary pressures.
The company believes it can meet all debt obligations through mid-2033 with current liquidity and cash flow.
Latest events from JBS
- Record $86.2B revenue and $2.02B net income in 2025, with margin pressure in North America.JBS
Q4 20258 Jul 2026 - Net sales up 11% to $21.6B–$22B, but EBITDA and net income declined; leverage at 2.77x.JBS
Q1 20268 Jul 2026 - Sustainable growth, margin expansion, and global diversification drive strong returns.JBS
Investor Day 2026 presentation18 Jun 2026 - Global protein leader with $88.3B revenue, margin growth, and expanding global footprint.JBS
Investor presentation18 May 2026 - Global protein leader with $88.3B revenue, expanding through diversification and strategic investment.JBS
Investor presentation13 May 2026 - Q2 2024 saw record margins, $329M net profit, and strong cash flow, led by poultry and pork.JBS
Q2 20241 Feb 2026 - Record 3Q24: $19.9B revenue, $2.2B EBITDA, $693M profit, leverage at 2.15x.JBS
Q3 202413 Jan 2026 - Record revenue, margin expansion, and lower leverage highlight robust 2024 performance.JBS
Q4 202420 Dec 2025 - Record revenue and net income growth offset margin pressures in US beef and pork.JBS
Q2 202523 Nov 2025